المؤلفون: Chun-li Lu, Liu-qing Yang, Xin-yan Jin, Thomas Friedemann, Yu-fei Li, Xue-han Liu, Xiao-ying Chen, Xiang-yun Zou, Bing-rui Zhang, Fu-xiang Wang, Yuan-long Lin, Yi-min Tang, Meng-li Cao, Ya-lin Jiang, You-fang Gao, Kui Liu, Zhen-gang Tao, Nicola Robinson, Sven Schröder, Jian-ping Liu, Hong-zhou Lu

المصدر: Frontiers in Pharmacology, Vol 15 (2024)

مصطلحات موضوعية: Shufeng Jiedu capsules, COVID-19, Chinese herbal medicine, symptom relief, randomized control trial, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2024.1383831/full; https://doaj.org/toc/1663-9812

URL الوصول: https://doaj.org/article/d0e499fd7e8e48c4bffece29b66e9bbc